Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb

CompletedOBSERVATIONAL
Enrollment

621

Participants

Timeline

Start Date

November 26, 2013

Primary Completion Date

October 21, 2024

Study Completion Date

October 21, 2024

Conditions
SurgeryHemoglobin
Interventions
DEVICE

Pulse CO-Oximetry Technology

"In addition to the standard pulse oximeter used for clinical care, up to six SpHb finger sensors will be applied to the patient. Additional sensors may also be applied to the forehead, neck, chest and ears.~Masimo FDA cleared pulse CO-Oximeter devices: Radical-7, Rad-87, Rad-57, Pronto, Pronto-7, for the noninvasive measurement of SpO2, PR, PI, PVI, SpCO, SpMet, and SpHb, total hemoglobin and respiratory rate.~No treatment decisions will be made based on the new technology and no extra medical procedures are required for the study."

OTHER

Blood draw

4mL arterial blood samples (up to 1 per hour), outside standard of care, are drawn throughout the surgical procedure and sent to UCDMC lab/Masimo lab for analysis.

Trial Locations (1)

95817

UC Davis Health, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT01997502 - Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb | Biotech Hunter | Biotech Hunter